Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2236 (LINC02236)
- Target
- LINC02236
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2236 (LINC02236) is a transcript of the human genome that belongs to the class of long intergenic non-coding RNAs (lincRNAs)[1][5]. These RNAs, defined as being longer than 200 nucleotides and not overlapping protein-coding genes, are autonomously transcribed and participate in the regulation of gene expression, chromatin architecture, and may act as enhancers, scaffolds, or decoys in cellular processes[1][5]. Although thousands of lincRNAs have been annotated, most—including LINC02236—remain poorly characterized functionally. In general, lincRNAs display tissue specificity and may fine-tune regulatory networks in development and disease, but there is currently limited specific evidence regarding the roles or disease associations of LINC02236[1][5].
- Other names
- RP11-332J15.1LINC02236
02
Mechanism of action
None. There are no drugs acting via this target; however, lincRNAs can influence gene expression through chromatin modification, enhancer function, and RNA-protein interactions
03
Biological functions
Chromatin remodelingGenome architecture modulationRNA stabilizationTranscriptional regulation (both enhancer-like and gene regulatory activity are known for the lincRNA family; specific functions for LINC02236 remain uncharacterized)
04
Disease associations
Other (No well-established disease association for LINC02236. However, some lincRNAs are implicated in cancer, immune regulation, and cell cycle control; these roles are general for the lincRNA class)
05
Safety considerations
None specific. As lincRNAs, cautious interpretation is needed in therapeutic applications due to tissue specificity, pleiotropy, and unclear systemic effects
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2236 (LINC02236).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2236 (LINC02236).